U.S. Markets close in 2 hrs 18 mins
  • S&P 500

    4,221.56
    +55.11 (+1.32%)
     
  • Dow 30

    33,875.97
    +585.89 (+1.76%)
     
  • Nasdaq

    14,145.08
    +114.70 (+0.82%)
     
  • Russell 2000

    2,283.45
    +45.71 (+2.04%)
     
  • Crude Oil

    73.83
    +2.19 (+3.06%)
     
  • Gold

    1,783.20
    +14.20 (+0.80%)
     
  • Silver

    26.06
    +0.09 (+0.33%)
     
  • EUR/USD

    1.1920
    +0.0055 (+0.4649%)
     
  • 10-Yr Bond

    1.4790
    +0.0290 (+2.00%)
     
  • Vix

    18.34
    -2.36 (-11.40%)
     
  • GBP/USD

    1.3935
    +0.0126 (+0.9113%)
     
  • USD/JPY

    110.2380
    +0.0880 (+0.0799%)
     
  • BTC-USD

    32,454.02
    -2,270.14 (-6.54%)
     
  • CMC Crypto 200

    789.42
    -60.92 (-7.16%)
     
  • FTSE 100

    7,062.29
    +44.82 (+0.64%)
     
  • Nikkei 225

    28,010.93
    -953.15 (-3.29%)
     

Why Cassava Sciences Stock Skyrocketed 145.1% in February

·2 min read
Why Cassava Sciences Stock Skyrocketed 145.1% in February
  • Oops!
    Something went wrong.
    Please try again later.

Promising results for the company's lead Alzheimer's drug have made Cassava one of 2021's most exciting stocks.